Table IV.
Multivariate analysis of the clinicopathological factors associated with OS in recurrent laryngeal carcinoma patients.
OS | |||
---|---|---|---|
Variables | Odds ratio | 95% CI | P-values |
Model Aa | |||
Grade | 1.295 | 0.997–1.682 | 0.053 |
Smoking index | 1.152 | 0.804–1.649 | 0.441 |
Age, years | 1.247 | 0.882–1.763 | 0.211 |
Initial T stage | 1.755 | 1.217–2.529 | 0.003 |
Nodal status | 1.496 | 0.998–2.243 | 0.051 |
Primary site | 1.134 | 0.849–1.516 | 0.395 |
Chemotherapy or no chemotherapy for the initial tumor | 1.130 | 0.964–1.326 | 0.132 |
Radiotherapy or no radiotherapy for the initial tumor | 1.149 | 0.965–1.370 | 0.120 |
Mode of recurrence | 1.145 | 0.885–1.481 | 0.303 |
Eligibility for surgery | 0.460 | 0.323–0.655 | <0.001 |
Disease-free interval | 0.454 | 0.319–0.646 | <0.001 |
Model Ba | |||
Age, years | 1.355 | 0.963–1.905 | 0.081 |
Smoking index | 1.342 | 0.944–1.907 | 0.101 |
Grade | 1.207 | 0.935–1.559 | 0.149 |
Primary site | 1.190 | 0.892–1.588 | 0.236 |
Initial T stage | 2.126 | 1.501–3.013 | <0.001 |
Nodal status | 1.893 | 1.261–2.841 | 0.002 |
Chemotherapy or no chemotherapy for the initial tumor | 1.063 | 0.904–1.250 | 0.460 |
Radiotherapy or no radiotherapy for the initial tumor | 1.167 | 0.980–1.389 | 0.083 |
Model Ca | |||
Disease-free interval | 0.439 | 0.308–0.613 | <0.001 |
Eligibility for surgery | 0.407 | 0.291–0.579 | <0.001 |
Mode of recurrence | 1.556 | 1.223–1.977 | <0.001 |
OS, overall survival; CI, confidence interval.